4-((5-Bromo-2-chlorophenyl)methyl)phenol

Its unique halogenated structure also suggests potential in agrochemicals or as a general fine chemical building block, but its main documented use is in complex drug synthesis. 4-((5-Bromo-2-chlorophenyl)methyl)phenol (also known as 4-(5-Bromo-2-chlorobenzyl)phenol) is used mainly as a key intermediate in synthesizing pharmaceuticals, particularly SGLT-2 inhibitors for type 2 diabetes, like Epagliflozin, by helping form complex tetrahydrofuran structures that target glucose reabsorption in the kidneys.